Recent Headlines
Within Pharmaceuticals
Fantastic Nutrition Launches Creatine Fantastic, a Science-Based Supplement Featuring Creatine and myHMB® for Enhanced Muscle Strength and Recovery
Research shows that combining creatine with myHMB can increase lean muscle mass up to 30% more than creatine alone (Wilson et al., 2014, Journal of the International Society of Sports Nutrition). This blend not only helps build muscle and recover faster, but also reduces muscle degradation, enhances athletic performance, and supports cognitive function—a total performance formula for both body and mind. - June 15, 2025 - Fantastic Nutrition
The Integritus Group a Division of SEMM Holdings Launches XceptView: Video Intelligence Built for Independent Retail, Food & Beverage, and Convenience Store Operators
SEMM Holdings, a trusted leader in operational excellence, compliance, and profit protection, today announced the launch of XceptView, a powerful new solution tailored to the needs of independent retailers, hospitality businesses, and convenience store owners. - June 11, 2025 - SEMM Holdings
3rd Annual ALS 100 Hole Challenge Set for June 17, 2025, in Hartford, CT
On Tuesday, June 17, 2025, twenty-four passionate golfers will take on a marathon challenge—playing 100 holes of golf in a single day—to raise critical funds and awareness in the fight against ALS. The third annual ALS 100 Hole Challenge will take place at Keney Park Golf Course in... - June 09, 2025 - ALS Therapy Development Institute
SEMM Holdings and Sharpvue Announce Strategic Partnership to Transform Operational Excellence and Surveillance Innovation
SEMM Holdings, a trusted leader in operational excellence through compliance, safety, and profit protection, today announced a strategic partnership with Sharpvue, a top innovator in mobile AI surveillance and commercial cloud video technology. This collaboration brings together deep domain expertise in asset protection, operational compliance and advanced surveillance technology to help organizations elevate safety, reduce risk, and increase operational transparency across industries. - June 06, 2025 - SEMM Holdings
H3Tech Welcomes Ruiban Coutinho as AI Healthtech Consultant
H3Tech, a healthcare technology and consulting firm, has appointed Ruiban Coutinho as AI Healthtech Consultant. With 14 years of experience in data analytics and business intelligence, Coutinho will leverage his expertise in AI, SAP BW/HANA, and Power BI to enhance H3Tech’s AI-driven healthcare solutions. - June 06, 2025 - H3Tech
Liminatus Pharma Announces Compliance with Nasdaq Filing Requirements
Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies, today announced that on June 3, 2025, it received a notification letter from Nasdaq indicating that it... - June 04, 2025 - Liminatus Pharma, Inc
Anzor Pharmaceuticals to Present at Chronic Kidney Disease Conference
Fibroblast growth factor technology constitutes a significant breakthrough in the treatment of metabolic and cancer-related diseases. - June 03, 2025 - Anzor Pharmaceuticals
Scientology Volunteer Ministers Reach Out with Practical Solutions at Kids Day in Sacramento
The Volunteer Ministers of the Sacramento Church of Scientology reach out at local community event to help families and children offering free on line courses for common everyday problems. - May 29, 2025 - Church of Scientology of Sacramento
No Collars, No Limits: HALO Chip Brings Real-Time GPS Tracking Under the Skin
HALO Technologies, Inc. has developed an implantable GPS microchip for pets and wildlife. Now in pre-launch, The HALO Chip offers discreet, real-time tracking without external devices. - May 28, 2025 - Halo Technologies Inc
Good Mana Knows the Secret to Powerful Health Benefits: ʻŌlena Gold Turmeric - A Premium Organic Supplement Grown in Nutrient-Dense Hawaiian Soil
Good Mana, based in Waimanalo, Hawai'i, is raising the industry standard for potency, purity and traceability of turmeric supplements with its premium ʻŌlena Gold Turmeric brand. - May 24, 2025 - Good Mana
Mindful Connections Therapy Announces New Ketamine Assisted Psychotherapy Services in Tucson, AZ
Mindful Connections Therapy, a leading provider of mental health services in Tucson Arizona, is proud to announce the launch of its new Ketamine Assisted Therapy services. This innovative treatment option offers a promising path to healing for individuals struggling with depression, trauma, and anxiety, providing a unique approach to mental wellness. - May 24, 2025 - Mindful Connections Therapy
Community Health Provider Aims to Make Health Care More Accessible
Affordable Behavioral Health Care is Hard to Find in Smaller, Underserved Communities. - May 23, 2025 - Total Point Healthcare
Phytobiosomes by Costas Picadas
Henri Dunant Hospital proudly presents Costas Picadas: Phytobiosomes, a unique exhibition of prints and digital installations that opened on Monday, May 19, 2025, and runs through Tuesday, September 30, 2025. The internationally recognized New York-based art historian Dr. Thalia Vrachopoulos curated the exhibition. - May 22, 2025 - Costas Picadas
Hemanext Welcomes New Member to Board of Directors
Geoff Crouse, an esteemed professional with over 25 years of leadership in the life sciences sector, joins the visionary leadership team guiding Hemanext’s mission to elevate the standard of care for patients who depend on transfusions. - May 21, 2025 - Hemanext
The New Gods of Medicine Summit Debuts in Cannes This June
Longevity Docs Presents: The New Gods of Medicine Summit Debuts in Cannes This June. - May 21, 2025 - Longevity Docs
Samantha's Outings Acquires First Transportation Van to Expand Services for Young Adults with Special Needs
After school ends, so do many of the support services available to individuals with special needs — leaving families facing an uncertain future. Samantha’s Outings, a San Diego-based nonprofit, is working to fill that critical gap. Today, the organization proudly announces the... - May 18, 2025 - Samantha's Outings
New QualiFam Autism Protocol Now Available in U.S. Treats Root Biological Causes Behind Symptoms
Developed by physician-scientist Dr. Ken Alibek, the QualiFam Protocol delivers results in as little as three months by targeting immune and infection-linked triggers. - May 16, 2025 - QualiFam
Microvascular Therapeutics: Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)
Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed data analysis of its Phase II trial of its new ultrasound contrast agent, MVT-100, CardiSon, in echocardiography. In this study, 16 subjects received either the predicate agent Perflutren, or CardiSon,... - May 15, 2025 - Microvascular Therapeutics, Inc.
Bench International Launches Bench On Demand to Deliver Executive Leadership at Fractional and Interim Capacity
Bench International, the longest-serving woman-founded executive search firm in the life sciences industry, today announced the launch of Bench On Demand, a new service offering flexible access to A-level executive talent on a fractional or interim basis. This initiative expands Bench’s... - May 13, 2025 - Bench International
Truvy® and Sweet Minerals Partner to Expand Global Health & Beauty Opportunities via Bytru.com
Truvy® has integrated the product and multi-level marketing (MLM) operations of Sweet Minerals into its business at Bytru, making Sweet Minerals’ celebrated beauty products available to a broader global audience. - May 12, 2025 - Truvy
ReLiftMD Reports Over 2,000 Successful Patient Treatments -- Re•Lift Me™ One-Hour Facial Rejuvenation Procedures Deliver Decade-Younger Looks Under Local Anesthesia
ReLiftMD LLC is changing the aesthetic landscape with its novel Re•Lift Me™ minimally invasive, long-lasting facial rejuvenation procedures. These procedures enable individuals to achieve a naturally youthful appearance, looking up to ten years younger, through a simple, one-hour procedure performed under local anesthesia. - May 07, 2025 - ReLiftMD, LLC
Industry-First Platform Combines AI-Powered Simulation and Lab Testing for Faster Biodegradation Assessment
Aropha's Biodegradation Studio is transforming how product developers approach biodegradability testing. The new platform combines rapid, AI-powered simulation with accredited laboratory services. Users can manage and accelerate every stage of biodegradability testing — from virtual screening to lab validation —through one, centralized hub. The studio helps R&D teams cut costs, screen more chemicals, speed up development and bring biodegradable materials to market faster. - May 06, 2025 - Aropha
Hemanext Expands Board of Directors with Two New Members
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces the appointment of two distinguished professionals to its Board of Directors. Joe Grogan and Phil Pead join the visionary leaders that are steering Hemanext’s path to improving the standard... - May 05, 2025 - Hemanext
MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico
MindScape Retreat in Cozumel, Mexico has released a groundbreaking case study showing a 70% average improvement in Parkinson’s symptoms following a 14-day ibogaine therapy program. Among 30 patients, 52% symptom relief was seen by Day 4, with further gains by Day 14. A quarter of participants who continued microdosing post-retreat maintained or improved results. The therapy, using Ibogaine HCl and TA, showed strong safety and potential neuroregenerative benefits via GDNF activation. - May 02, 2025 - MindScape Retreat
AffinIT Secures $600,000 Funding Round to Accelerate Growth in Managed IT Services
AffinIT, a managed IT services provider, secured $600K funding to expand its AI-powered platform for small and mid-market companies. Founded in 2024, AffinIT offers end-user support, network management, cybersecurity and cloud solutions. The funding will support growth and product development after a year of 100% revenue growth. - May 02, 2025 - AffinIT, LLC
Vetirus Pharmaceuticals Acquires Enso Discoveries to Expand Regenerative Medicine Portfolio
Vetirus Pharmaceuticals, a multinational company headquartered in Naples, Florida, and London, UK, announced its acquisition of Enso Discoveries, LLC, a Manhattan, Kansas-based biotech company specializing in regenerative medicine. The acquisition was revealed at the 10th annual Animal Health, Nutrition, and Technology Innovation Europe. - April 30, 2025 - Vetirus Animal Health
Mirror Biologics Announces Publication of Clinical Results Showing Potential for Allo-Priming to Provide Broad Protection to Elderly from Respiratory Viral Infection
A new approach for pandemic preparedness and protection of the elderly from any type of respiratory viral infection. Five injections over two weeks provides possible universal viral protection without need for booster shots. - April 28, 2025 - Mirror Biologics, Inc.
International Vitamin Corporation (IVC) Appoints Nora Dowell as Senior Vice President of Quality, Regulatory, and R&D
IVC is pleased to announce the appointment of Nora Dowell as Senior Vice President of Quality, Regulatory, and R&D, marking a significant step forward in the company’s ongoing commitment to delivering high-quality, compliant, and innovative health and wellness products. Nora brings more than 30 years of experience in regulatory compliance and quality management systems, with deep expertise in cGMP, QMS, FSMA/FSVP, training, auditing, labeling, and supplier qualifications. - April 26, 2025 - International Vitamin Corporation
MindScape Retreat in Cozumel, Mexico, Offers Innovative Ibogaine Therapy to Address Long-Term SSRI Effects and Serotonin Syndrome Risks
MindScape Retreat in Cozumel, Mexico, offers medically supervised ibogaine treatment to help individuals safely discontinue SSRIs and address associated long-term effects, including the risk of serotonin syndrome. By promoting neuroplasticity and restoring neurotransmitter balance, ibogaine therapy at an Ibogaine Retreat called MindScape Retreat provides a holistic approach to mental health recovery in a serene and supportive environment. - April 25, 2025 - MindScape Retreat
Precision Antibody’s Founder and CEO to Speak at the 2025 Drug Discovery Strategic Summit in Boston
Dr. Jun Hayashi and Dr. Ginette Serrero of Precision Antibody will speak at the 2025 Drug Discovery Strategic Summit in Boston, highlighting advances in monoclonal antibody development and its role in accelerating drug discovery. - April 25, 2025 - Precision Antibody
Caris Life Sciences Collaborates with Meaningful Insights Biotech Analytics (MiBA) to Advance Oncology Education and Quality of Care
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced a strategic collaboration with MiBA, an innovative healthcare technology company to provide physician education and insights to accelerate research, identify and... - April 24, 2025 - MiBA
Parvus Announces Achievement of First Milestone from its Collaboration Agreement with AbbVie to Develop IBD Therapies Based on the Parvus Nanomedicine Platform Technology
IND-enabling nonclinical and manufacturing activities executed by Parvus met prospective criteria resulting in the first milestone payment from AbbVie. - April 21, 2025 - Parvus Therapeutics U.S., Inc.
New GDP Training with Certificate
Pharma Lessons has launched another new online training. This time the topic is Good Distribution Practice. The training explores the regulatory guidelines that govern the wholesale distribution of medicinal products. Trainees that decide to enroll into that course will get familiar with the main... - April 16, 2025 - Pharma Lessons
Ember Group Consulting & Ember Group Search Bolsters Talent Acquisition Capabilities with Appointment of Taylor Morrison as VP of Talent & MD of Ember Group Search
Ember Group appoints Taylor Morrison as VP of Talent & Managing Director of Ember Group Search. With 20+ years of global talent acquisition experience, Taylor will lead the firm's talent acquisition function, focusing on identifying and retaining top talent to drive business growth and spark careers. - April 15, 2025 - Ember Group Consulting LLC
GENINVO Announces Its Latest Innovation – Confidential Information Scanner (CIS) Tool
GENINVO, a leading provider of life science technology solutions, is proud to announce the launch of its latest innovation – the Confidential Information Scanner (CIS) Tool. This tool is designed to help organizations identify publicly available company confidential information (CCI) across... - April 12, 2025 - GenInvo, Inc.
Devonics Automation (Booth #4413) to Participate in Automate 2025, May 12–15, in Detroit, Michigan, USA
Devonics Automation will showcase collaborative robot (cobot) solutions designed to meet growing automation demands at the most influential automation event in the Americas. - April 07, 2025 - Devonics Automation
Minus K Congratulates to the following winners of their 2024/2025 Educational Giveaway
Celebrating its’ tenth year of their U.S. Educational Giveaway, Minus K Technology has to-date granted over $100,000 of its superior performing patented Negative-Stiffness low-frequency passive mechanical vibration isolators to colleges and universities in the USA. - April 03, 2025 - Minus K Technology Inc.
Wallflower Cannabis House Announces Second Location in Inspirada, Henderson
Wallflower Cannabis House, a renowned dispensary for Las Vegas locals, is thrilled to announce the opening of its second location on April 4 at 8am in the Inspirada area of Henderson, at 3485 Volunteer Blvd. Building on the success of its original location on Blue Diamond Road since 2020,... - April 02, 2025 - Wallflower Cannabis House
Apeximmune Therapeutics Announces Successful Close of Series A Fundraising Round to Advance Next-Generation Immunotherapies
Apeximmune Therapeutics, a biotechnology company pioneering next-generation immunotherapies, today announced the successful close of its Series A financing round, raising $21.3 million, exceeding its original goal of $20 million. The funding was led by PharmaEssentia Corporation, with participation... - April 01, 2025 - Apeximmune Therapeutics
Huntington Study Group Announces Executive Director of Clinical Operations
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to introduce Carolyn Schultz-Walter as the Executive Director of Clinical Operations. With over 25 years of global clinical operations experience spanning both sponsor and clinical research... - March 31, 2025 - Huntington Study Group
BlueCallom Launches COMPLY-AI, Challenging the $36 Billion Industry with a New AI Solution
BlueCallom today announced the launch of COMPLY-AI, an autonomous compliance management solution designed to support enterprise teams in meeting evolving regulatory requirements. COMPLY-AI offers an integrated platform that delivers self-service compliance assessments, saving over 2,000 expert hours annually. It also reduces operational delays and improves the time-to-market. - March 29, 2025 - BlueCallom AG
Dr. Mike Chan: Leading the Future of Organ-Specific Stem Cell Therapies with Revolutionary Treatments in Regenerative Medicine
Dr. Mike Chan is a global leader in regenerative medicine, transforming lives with stem cells, exosomes, and peptides. His innovative treatments regenerate tissues, restore healing, and enhance vitality. Patients experience renewed hope, improved energy, and recovery from chronic conditions. His groundbreaking work is reshaping the future of healthcare. - March 28, 2025 - Dr. Mike Chan
Carl Wittwer, MD, PhD, Joins PathogenDx’s Board of Advisors
Carl Wittwer, MD PhD, Professor Emeritus of Pathology at the University of Utah, a Co-Founder of Idaho Technologies/Biofire and previously spent 35+ years as a Medical Director at ARUP Laboratories is joining PathogenDx as Technology & Scientific Board Advisor to help advance its D3 Array technology in terms of Speed, Cost and Performance. - March 25, 2025 - PathogenDx, Inc.
Thar Process and Clean Heat Technologies Integrate CO2 Heat Pump Technology to Make Supercritical CO2 Technology a Low Cost Solution
Thar Process and Clean Heat Technologies have successfully engineered, integrated and installed electric heat pumps using CO2 - R744 - as the upcycled, natural refrigerant. The technology partnership means that Thar Process' clients can benefit from lower operating costs. Thar is known for it's innovative use of CO2 for extracting flavors, fragrances, medicinal and therapeutic compounds both in it's GMP certified facility in Pittsburgh and at client sites globally. - March 24, 2025 - Thar Process
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of hard-to-treat cancers. In combination with standard-of-care chemotherapy, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, prevents cancer recurrence, improves complete response rate and survival in experimental pancreatic cancer. In combination with anti-PD-L1 treatment, it overcomes pancreatic cancer resistance to immunotherapy. - March 21, 2025 - SignaBlok, Inc.
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug at the Respiratory Innovation Summit and American Thoracic Society International Conference 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of sepsis and pulmonary diseases. In experimental sepsis, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, protects from death with the level of protection not declining at delayed treatment times. In pulmonary inflammation and fibrosis in rats and mice, it reduces neutrophil infiltration in the lungs and reverses fibrosis. - March 21, 2025 - SignaBlok, Inc.
Addressing the Growing Crisis in Pain Management Medication Access
PMC Pharmacy Advocates for Transparent, Collaborative Solutions to Reduce Risk and Ensure Patient Care - A Path Forward for Pain Management Medication Access - March 19, 2025 - PMC Pharmacy
ALS Therapy Development Institute Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the... - March 18, 2025 - ALS Therapy Development Institute
Samantha's Outings Celebrates a Year of Empowerment and Community Engagement for Individuals with Autism
What Samantha's Outings has done in one year and where they will go in the future. - March 17, 2025 - Samantha's Outings
ConductScience Accepted Into NVIDIA Connect Program, Advancing AI-Driven Behavioral Neuroscience Research Solutions
ConductScience joins the NVIDIA Connect program, accelerating AI advancements in behavioral research. This collaboration enhances ConductVision, ConductInsecta, ConductNest, and GaitMaster, optimizing research on locomotion, cognition, and social behavior across species. With NVIDIA’s support, ConductScience gains access to GPU-accelerated computing, engineering resources, and training, driving innovation in neuroscience, genetics, and medicine. - March 16, 2025 - ConductScience